Eribulin Mesylate
- Product NDC
- 43598-125
- 11-digit product format
- 435980125
- Labeler code
- 43598
- Product ID
- 43598-125_5b72f089-3089-d1f4-1138-d21ea2958492
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Eribulin Mesylate
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Dr. Reddys Laboratories Inc
- Application
- ANDA217473
- Marketing category
- ANDA
- Marketing start
- 2026-01-22
- Substance
- ERIBULIN MESYLATE
- Active strength
- .5 mg/mL
- Pharmacologic classes
- Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Eribulin Mesylate
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ERIBULIN MESYLATE | .5 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | AV9U0660CW |
| Rxcui | 1045456 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 43598-125-11 | Eribulin Mesylate | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION | 2 | | 5 |
| 43598-125-11 | Eribulin Mesylate | 1 in 1 CARTON | INJECTION | 1 | | 5 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 43598-125-11 | 43598012511 | 1 VIAL, SINGLE-DOSE in 1 CARTON (43598-125-11) / 2 mL in 1 VIAL, SINGLE-DOSE | 2026-01-22 | No | No | Current |